Abstract:Abstract Proteolysis-targeting chimeras (PROTACs), which selectively degrade targeted proteins by the ubiquitin-proteasome system, have emerged as a novel therapeutic technology with potential advantages over traditional inhibition strategies. In the past few years, this technology has achieved substantial progress and two PROTACs have been advanced into phase I clinical trials. However, this technology is still maturing and the design of PROTACs remains a great challenge. In order to promote the rational design of PROTACs, we present PROTAC-DB, a web-based open-access database that integrates structural information and experimental data of PROTACs. Currently, PROTAC-DB consists of 1662 PROTACs, 202 warheads (small molecules that target the proteins of interest), 65 E3 ligands (small molecules capable of recruiting E3 ligases) and 806 linkers, as well as their chemical structures, biological activities, and physicochemical properties. Except the biological activities of warheads and E3 ligands, PROTAC-DB also provides the degradation capacities, binding affinities and cellular activities for PROTACs. PROTAC-DB can be queried with two general searching approaches: text-based (target name, compound name or ID) and structure-based. In addition, for the convenience of users, a filtering tool for the searching results based on the physicochemical properties of compounds is also offered. PROTAC-DB is freely accessible at http://cadd.zju.edu.cn/protacdb/.

What problem does this paper attempt to address?

The problem this paper attempts to address is: To facilitate the rational design of proteolysis-targeting chimeras (PROTACs), the authors have developed an online database called PROTAC-DB. This database integrates structural information and experimental data of PROTACs, aiming to help researchers more easily query, browse, and analyze the structures and related properties of PROTACs. Specifically, the paper mainly addresses the following issues: 1. **Challenges in PROTACs Design**: As a novel therapeutic technology, PROTACs have potential advantages in selectively degrading target proteins, but their design still faces significant challenges. PROTAC-DB provides a valuable resource by collecting and annotating a large amount of experimental data and structural information of PROTACs, helping researchers overcome these design challenges. 2. **Comprehensiveness and Accessibility of Data**: Existing databases, although containing some information on PROTACs, are relatively limited in quantity and experimental information. PROTAC-DB is the first online database specifically for PROTACs, containing 1662 PROTACs, 202 warheads, 65 E3 ligands, and 806 linkers, along with their chemical structures, biological activities, and physicochemical properties. 3. **User-Friendly Query and Browsing Tools**: PROTAC-DB provides text and structure-based search tools, as well as filtering tools based on the physicochemical properties of compounds, enabling users to conveniently retrieve and analyze data. Additionally, detailed compound information pages are provided, including structures, biological activities, and physicochemical properties. 4. **Data Download and Sharing**: All data on PROTACs, warheads, E3 ligands, and linkers can be downloaded in SDF or CSV file formats, facilitating further research and analysis by users. In summary, the main purpose of this paper is to support the design and research of PROTACs by establishing a comprehensive, user-friendly online database, thereby promoting the development of this emerging technology.

PROTAC-DB: an online database of PROTACs

PROTAC-DB 2.0: an updated database of PROTACs

PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

An overview of PROTACs: a promising drug discovery paradigm

PROTACs: Great Opportunities for Academia and Industry

Development of PROTACs Using Computational Approaches

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges

DiffPROTACs is a deep learning-based generator for proteolysis targeting chimeras

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future

PROTACs technology for targeting non-oncoproteins: Advances and perspectives

Developments of PROTACs technology in immune-related diseases

PROTACs: A Novel Strategy for Cancer Drug Discovery and Development

PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy

PROTAC technology: From drug development to probe technology for target deconvolution

Chemistries of bifunctional PROTAC degraders

Proteolysis-targeting chimeras (PROTACs) in cancer therapy

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy

PROTACable Is an Integrative Computational Pipeline of 3-D Modeling and Deep Learning To Automate the De Novo Design of PROTACs

A bibliometric analysis of PROTAC from 2001 to 2021